Patents by Inventor Freddie Stevens

Freddie Stevens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Histamine H3 Receptor Inhibitors, Preparation and Therapeutic Uses
    Publication number: 20080015235
    Abstract: The present invention discloses novel compounds of Formula I or pharmaceutically acceptable salts thereof, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical. compositions comprising compounds of Formula I as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.
    Type: Application
    Filed: October 11, 2005
    Publication date: January 17, 2008
    Inventors: Cynthia Jesudason, Freddie Stevens
  • Oxazole derivatives as histamine h3 receptor agents,preparation and therapeutic uses
    Publication number: 20070197604
    Abstract: The present invention discloses novel aryl oxazole compounds of Formula I (I), or pharmaceutically acceptable salts thereof, which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing and using such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using these compositions to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.
    Type: Application
    Filed: July 14, 2005
    Publication date: August 23, 2007
    Inventors: Lisa Beavers, Serge Boulet, Terry Finn, Robert Gadski, Willaim Hornback, Cynthia Jesudason, Richard Pickard, Freddie Stevens, Grant Vaught
  • Histamine h3 receptor antagonists, preparation and therapeutic uses
    Publication number: 20060167046
    Abstract: The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof which have histamine-II3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I), as well as methods or using them to treat obesity and other histamine II3 receptor-related diseases.
    Type: Application
    Filed: September 12, 2003
    Publication date: July 27, 2006
    Applicant: Eli Lilly and Company Patent Division
    Inventors: Lisa Beavers, Don Finley, Robert Gadski, Philip Hipskind, Cynthia Jesudason, Richard Pickard, Freddie Stevens
  • Gutter cover having a unique interlocking bracket
    Patent number: 6993871
    Abstract: The invention is a bracket for installing a gutter cover for ducting rainwater to a rainwater gutter, where the gutter cover prevents debris from entering the gutter. The bracket is roughly shaped like three extended fingers, where each finger is a strut. The struts converge at a junction. The various struts are a lifting strut that supports the leading hooked frontal edge of a gutter cover, a stabilizing strut that has a hooked end that interlocks with the hooked edge of a frontal rim of a gutter trough, and a bracing strut that is a leg stemming from the junction to a bottom portion of the gutter.
    Type: Grant
    Filed: February 5, 2004
    Date of Patent: February 7, 2006
    Assignee: Gutter Pro USA LLC
    Inventors: Thomas Roy Richard, Jason Andrew Herald, Freddie Steven White
  • 3-Substituted oxindole beta3 agonists
    Publication number: 20050159473
    Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula I: or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.
    Type: Application
    Filed: March 16, 2005
    Publication date: July 21, 2005
    Inventors: Daniel Sall, Jolie Bastian, Cynthia Jesudason, Don Finley, Freddie Stevens, Vincent Rocco, Patrick Spinazze, John He, John Werner, William Trankle, Andrew Ratz, Theo Schotten, Gerd Reuhter
  • Beta 3 adrenergic agonists
    Publication number: 20050080110
    Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula (I); or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful, e.g., for treating Type 2 diabetes and/or obesity.
    Type: Application
    Filed: August 6, 2002
    Publication date: April 14, 2005
    Inventors: Daniel Sall, Jolie Bastian, Rushad Karanjawala, Cynthia Jesudason, Theo Schotten, Britta Evers, Gerd Reuhter, Don Finley, Freddie Stevens, Vincent Rocco, Patrick Spinazze, John He, John Werner, William Trankle, Andrew Ratz
  • 3-Substituted oxindole beta3 agonists
    Publication number: 20050054713
    Abstract: The present invention relates to a ?3 adrenergic receptor agonist of formula I: or a pharmaceutical salt thereof; which is useful for treating Type II diabetes and/or obesity.
    Type: Application
    Filed: October 21, 2004
    Publication date: March 10, 2005
    Inventors: Cynthia Jesudason, Daniel Sall, Freddie Stevens, John Werner